Statement of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:
Net income attributable to common shareholders	$ 3,252,328	$ 9,265,631
Accretion of investments	(4,861,780)	(998,853)
Realized investment gains, net	(889,253)	(14,305,312)
Unrealized trading gains included in income	36,876	352,761
Realized trading (gains) losses included in income	288,631	(2,462,205)
Amortization of deferred policy acquisition costs	56,432	62,048
Amortization of cost of insurance acquired	1,064,353	1,145,501
Depreciation	1,260,697	1,242,149
Net income attributable to noncontrolling interest	617,684	681,805
Charges for mortality and administration of universal life and annuity products	(6,885,257)	(7,067,717)
Interest credited to account balances	5,118,692	5,192,370
Change in accrued investment income (loss)	11,851	(1,308,049)
Change in reinsurance receivables	1,116,386	3,756,502
Change in policy liabilities and accruals	(6,146,134)	(4,987,472)
Change in income taxes payable	(3,318,794)	2,082,289
Change in other assets and liabilities, net	(1,666,512)	(3,292,668)
Net cash provided by (used in) operating activities	(10,943,800)	(10,641,220)
Cash flows from investing activities:
Fixed maturities available for sale	37,802,120	98,640,115
Equity securities available for sale	681,209	1,953,434
Trading securities	24,017,415	15,299,053
Mortgage loans	15,428,176	7,546,798
Discounted mortgage loans	17,424,049	6,533,313
Real estate	8,880,306	16,411,306
Policy loans	3,617,041	3,678,795
Total proceeds from investments sold and matured	107,850,316	150,062,814
Cost of investments acquired:
Fixed maturities available for sale	(34,443,048)	(128,314,307)
Equity securities available for sale	(10,428,300)	(13,834,829)
Trading securities	(24,105,644)	(16,597,713)
Mortgage loans	(4,539,234)	(15,945,433)
Discounted mortgage loans	(12,222,291)	(6,299,298)
Real estate	(13,014,568)	(15,829,535)
Policy loans	(2,886,428)	(2,958,138)
Short-term investments	(25,000)	(6,268,320)
Total cost of investments acquired	(101,664,513)	(206,047,573)
Disposal (purchase) of property and equipment	0	17,440
Net cash used in investing activities	6,185,803	(55,967,319)
Cash flows from financing activities:
Policyholder contract deposits	5,798,948	6,006,858
Policyholder contract withdrawals	(5,311,025)	(6,644,674)
Proceeds from notes payable/line of credit	3,000,000	16,321,035
Payments of principal on notes payable/line of credit	(2,760,420)	(6,994,726)
Purchase of treasury stock	(286,988)	(928,902)
Proceeds from sale of subsidiary	0	0
Non-controlling distributions of consolidated subsidiary	834,854	(3,236,187)
Cash received in reinsurance recapture	0	2,480,706
Net cash provided by (used in) financing activities	1,275,369	7,004,110
Net increase (decrease) in cash and cash equivalents	(3,482,628)	(59,604,429)
Cash and cash equivalents at beginning of period	23,321,246	82,925,675
Cash and cash equivalents at end of period	$ 19,838,618	$ 23,321,246